Contact Us
contact us
Search
What Our Partners Say
What Our Partners Say
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Human Health Partnering
Human Health Partnering
Ethics and Compliance
Ethics and Compliance
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Topline data from FIBRONEER™-IPF show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] at week 52 versus placebo.
Lung Diseases
Lung Diseases
More Potential
Boehringer Ingelheim steps up its commitment to sustainable development, building on its historical success in addressing unmet health needs and increasing its ambitions to tackle global health and societal challenges.
Animal Health Innovation
Animal Health Innovation
Partnering Culture
Partnering Culture
The Research Process
The Research Process
Parasiticides
Parasiticides
Therapeutics
Therapeutics
Vaccines
Vaccines
Pets
Pets
Meet our Team
Meet our Team
Animal Health
Animal Health
Partnering
Partnering
Scleroderma
Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs
More Green
More Green
Stroke
Stroke
Media Overview
Media Overview
Corporate Profile
Corporate Profile
Human Health Innovation
Human Health Innovation
COPD & Asthma
COPD & Asthma